CRP and myeloid sarcoma: A significant (p < 0.05) variation in the mean ± SD CRP (mean ± SD: highly severe (HS), 102.4 ± 22.9; moderately severe (MS), 21.3 ± 6.9; p-value < 0.001), D-dimer (mean ± SD: highly severe (HS), 661.1 ± 80.6; moderately severe (MS), 348.7 ± 42.9; p-value < 0.001), and ferritin (mean ± SD: highly severe (HS), 875.8 ± 126.8; moderately severe (MS), 593.4 ± 67.3; p-value < 0.001) of the HS and MS groups of the participants were observed (Table 2).